title: Expression of kinin receptors on eosinophils: comparison of asthmatic patients and healthy subjects.
abstract: Eosinophils contribute to asthmatic airway inflammation by releasing cysteinyl leukotrienes (cysLT) and other inflammatory mediators, and bradykinin (BK) induces bronchoconstriction in asthmatic patients. The aims of this study were to investigate kinin receptor expression on eosinophils of asthmatic and healthy subjects and to assess the effects of kinin stimulation on eosinophils, which were isolated from peripheral blood of asthmatic (n=27) and healthy subjects (n=14). Kinin B(1) and B(2) receptors (B(1)R and B(2)R, respectively) and mRNA expression were investigated by quantitative confocal microscopy, flow cytometry, and RT-PCR. Intracellular Ca(2+) was assessed by live-cell fluorescence confocal microscopy. Production of cysLT and eosinophil migration in response to BK and Lys-des[Arg(9)]-BK were assessed. Eosinophils expressed kinin B(1)R and B(2)R mRNA and proteins. Quantitative immunofluorescence analysis indicated that expression of B(1)R and B(2)R proteins was significantly greater in eosinophils of asthmatic patients compared with those of nonasthmatic subjects. However, kinin B(1)R and B(2)R mRNA expression did not differ significantly between these groups. Expression of kinin B(1)R and mRNA was decreased in patients using high doses of inhaled corticosteroids and in eosinophils treated with a corticosteroid in vitro. Kinin B(1) and B(2) agonists up-regulated expression of their respective receptors but did not increase intracellular Ca(2+) or the production of cysLT or enhance eosinophil migration significantly. Up-regulation of kinin receptor expression in eosinophils of asthmatic patients may be a consequence of inflammation, whereby enhanced release of kinin peptides has a positive-feedback effect on kinin receptor expression. Importantly, anti-inflammatory corticosteroids down-regulated the expression of the kinin B(1)R.
authors.affiliation: Lung Institute of Western Australia, Centre for Asthma, Allergy and Respiratory Research, The University of Western Australia, Perth, Australia.
authors.forename: Cornelia M
authors.initials: CM
authors.lastname: Bertram
authors.forename: Neil L
authors.initials: NL
authors.lastname: Misso
authors.forename: Mirjana
authors.initials: M
authors.lastname: Fogel-Petrovic
authors.forename: Carlos D
authors.initials: CD
authors.lastname: Figueroa
authors.forename: Paul S
authors.initials: PS
authors.lastname: Foster
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Thompson
authors.forename: Kanti D
authors.initials: KD
authors.lastname: Bhoola
mesh_terms: D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D001249:Asthma / Q000473:pathology*; D002118:Calcium / Q000032:analysis; D016022:Case-Control Studies; D002634:Chemotaxis, Leukocyte; D004804:Eosinophils / Q000378:metabolism* / Q000473:pathology; D025461:Feedback, Physiological; D005786:Gene Expression Regulation; D006801:Humans; D007705:Kinins / Q000819:agonists; D015289:Leukotrienes / Q000096:biosynthesis; D012333:RNA, Messenger / Q000032:analysis; D043783:Receptor, Bradykinin B1 / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D043782:Receptor, Bradykinin B2 / Q000032:analysis / Q000235:genetics* / Q000378:metabolism
chemical_list: D000305:Adrenal Cortex Hormones; D007705:Kinins; D015289:Leukotrienes; D012333:RNA, Messenger; D043783:Receptor, Bradykinin B1; D043782:Receptor, Bradykinin B2; D002118:Calcium